Skip to main content
. 2022 Nov 25;13:1042394. doi: 10.3389/fendo.2022.1042394

Figure 4.

Figure 4

 A nomogram to predict axillary pCR after NST in cN+ breast cancer patients NST, neoadjuvant systemic therapy; ER, estrogen receptor; HER2, human epidermal growth factor receptor 2; pCR, pathologic complete response.